AI Engines For more Details: Perplexity Kagi Labs You
Gastroesophageal Reflux Disease (GERD): Tenatoprazole, like other PPIs, is used to treat GERD by reducing the production of stomach acid. This can help alleviate symptoms such as heartburn, acid reflux, and esophagitis.
Peptic Ulcers: PPIs are often used in the treatment of peptic ulcers, including gastric ulcers and duodenal ulcers. By reducing stomach acid production, tenatoprazole can help promote healing and prevent ulcer recurrence.
Zollinger-Ellison Syndrome: This rare condition involves excessive gastric acid production due to gastrin-secreting tumors in the pancreas or duodenum. PPIs like tenatoprazole can help manage symptoms and reduce acid production in individuals with this syndrome.
Helicobacter pylori Infection: Tenatoprazole is sometimes used as part of a combination therapy to eradicate Helicobacter pylori bacteria in the stomach, which can help heal ulcers and prevent their recurrence.
Reflux Esophagitis: Inflammation of the esophagus due to chronic acid reflux can be treated with PPIs like tenatoprazole, which help reduce acid exposure to the esophageal lining.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Akkermansia muciniphila | Reduces |
| species | Escherichia coli | Reduces |
| species | Lacticaseibacillus paracasei | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
| ADHD | 0.3 | 0.3 | 0 |
| Allergic Rhinitis (Hay Fever) | 1.2 | 0.1 | 11 |
| Allergies | 1.9 | 0.5 | 2.8 |
| Allergy to milk products | 0.4 | 0.6 | -0.5 |
| Alzheimer's disease | 1.3 | 1 | 0.3 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.7 | 0.4 | 0.75 |
| Ankylosing spondylitis | 0.7 | 0.9 | -0.29 |
| Anorexia Nervosa | 0.3 | 0.3 | 0 |
| Antiphospholipid syndrome (APS) | 0.1 | 0.3 | -2 |
| Asthma | 0.7 | 0.1 | 6 |
| Atherosclerosis | 0.4 | 0 | 0 |
| Atrial fibrillation | 0.3 | 0.9 | -2 |
| Autism | 2.5 | 1.3 | 0.92 |
| Autoimmune Disease | 0.6 | 0.6 | |
| benign prostatic hyperplasia | 0.6 | 0.6 | |
| Biofilm | 0.7 | 0.7 | |
| Bipolar Disorder | 1.5 | 0.6 | 1.5 |
| Brain Trauma | 0.3 | -0.3 | |
| Breast Cancer | 0.1 | 0.1 | |
| Cancer (General) | 0.7 | -0.7 | |
| Carcinoma | 1.5 | 0.3 | 4 |
| Celiac Disease | 0.1 | 0.6 | -5 |
| Cerebral Palsy | 0 | 0.3 | 0 |
| Chronic Fatigue Syndrome | 2.1 | 0.4 | 4.25 |
| Chronic Kidney Disease | 1.5 | 0.3 | 4 |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.1 | 0.1 | |
| Chronic Urticaria (Hives) | 0.7 | 0.1 | 6 |
| Coagulation / Micro clot triggering bacteria | 0.7 | 0.3 | 1.33 |
| Cognitive Function | 0.3 | 0.3 | |
| Colorectal Cancer | 1.9 | 0.1 | 18 |
| Constipation | 0.9 | 0.9 | |
| Coronary artery disease | 1.6 | 1.6 | |
| COVID-19 | 2 | 1.4 | 0.43 |
| Crohn's Disease | 2.2 | 0.4 | 4.5 |
| cystic fibrosis | 0.7 | 0.7 | |
| d-lactic acidosis (one form of brain fog) | 0.1 | 0.1 | |
| deep vein thrombosis | 1 | 0.3 | 2.33 |
| Depression | 3.5 | 2.2 | 0.59 |
| Eczema | 1.2 | 1.2 | |
| Endometriosis | 0.7 | 0.4 | 0.75 |
| Epilepsy | 0.7 | 0.1 | 6 |
| erectile dysfunction | 1.2 | 1.2 | |
| Fibromyalgia | 0.3 | 0.3 | |
| Functional constipation / chronic idiopathic constipation | 1 | 0.3 | 2.33 |
| gallstone disease (gsd) | 1.6 | 0 | 0 |
| Generalized anxiety disorder | 1.6 | 0 | 0 |
| Gout | 0.3 | 0.3 | 0 |
| Graves' disease | 0.3 | 0.3 | 0 |
| Gulf War Syndrome | 0.1 | -0.1 | |
| Hashimoto's thyroiditis | 0.3 | 0.3 | 0 |
| Heart Failure | 1.6 | 0.3 | 4.33 |
| Hidradenitis Suppurativa | 0.3 | 0.3 | |
| High Histamine/low DAO | 0.1 | 0.3 | -2 |
| hypercholesterolemia (High Cholesterol) | 0.1 | 0.1 | 0 |
| hyperglycemia | 1.3 | 0.1 | 12 |
| Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
| hypersomnia | 0.3 | -0.3 | |
| hypertension (High Blood Pressure | 1 | 0.6 | 0.67 |
| Hypothyroidism | 0 | 0.3 | 0 |
| Hypoxia | 0.7 | 0.7 | |
| IgA nephropathy (IgAN) | 0.6 | 0.6 | 0 |
| Inflammatory Bowel Disease | 2.2 | 0.7 | 2.14 |
| Insomnia | 0.4 | -0.4 | |
| Intelligence | 0.1 | 0.1 | |
| Intracranial aneurysms | 0.3 | 0.3 | |
| Irritable Bowel Syndrome | 1.7 | 0.4 | 3.25 |
| ischemic stroke | 0.4 | 0.6 | -0.5 |
| Liver Cirrhosis | 1.6 | 1.4 | 0.14 |
| Long COVID | 1.5 | 0.8 | 0.88 |
| Lung Cancer | 0.9 | 0.4 | 1.25 |
| Lymphoma | 0.6 | 0.6 | |
| Mast Cell Issues / mastitis | 0.6 | 0.3 | 1 |
| ME/CFS without IBS | 1.6 | 1.6 | |
| Menopause | 0 | 0 | |
| Metabolic Syndrome | 2.2 | 0.7 | 2.14 |
| Mood Disorders | 3.5 | 1.9 | 0.84 |
| multiple chemical sensitivity [MCS] | 0 | 0 | |
| Multiple Sclerosis | 2.2 | 0.3 | 6.33 |
| Multiple system atrophy (MSA) | 0.1 | 0.3 | -2 |
| myasthenia gravis | 0.6 | 0.6 | |
| neuropathic pain | 0.3 | 0 | 0 |
| Neuropathy (all types) | 0.3 | 0.6 | -1 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.1 | 0.1 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1 | 0.4 | 1.5 |
| NonCeliac Gluten Sensitivity | 0.4 | 0.4 | |
| Obesity | 2.5 | 2.5 | 0 |
| obsessive-compulsive disorder | 0.8 | 0.7 | 0.14 |
| Osteoarthritis | 1.2 | 0.3 | 3 |
| Osteoporosis | 1.2 | 0.1 | 11 |
| Parkinson's Disease | 2.1 | 1 | 1.1 |
| Polycystic ovary syndrome | 1.6 | 0.8 | 1 |
| Primary sclerosing cholangitis | 0.9 | -0.9 | |
| Psoriasis | 0.4 | 0.1 | 3 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.2 | 2.2 | |
| Rosacea | 0.3 | 0.3 | |
| Schizophrenia | 0.9 | 0.3 | 2 |
| scoliosis | 0.1 | 0.6 | -5 |
| Sjögren syndrome | 0.6 | 0.6 | |
| Sleep Apnea | 0.3 | 0.6 | -1 |
| Slow gastric motility / Gastroparesis | 0.4 | 0.4 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.1 | 0.1 | |
| Stress / posttraumatic stress disorder | 0.1 | 0.7 | -6 |
| Systemic Lupus Erythematosus | 1.8 | 0.4 | 3.5 |
| Tic Disorder | 0.3 | 0.3 | |
| Tourette syndrome | 0 | 0 | |
| Type 1 Diabetes | 1.3 | 0.3 | 3.33 |
| Type 2 Diabetes | 2.2 | 0.5 | 3.4 |
| Ulcerative colitis | 0.7 | 0.7 | 0 |
| Unhealthy Ageing | 1.2 | 0 | 0 |
| Vitiligo | 0.3 | 0 | 0 |
